Bavarian Nordic A/S is a Danish biotechnology company that specializes in the development, manufacturing, and commercialization of vaccines for infectious diseases and cancer. Bavarian Nordic is a fully integrated vaccine company focused on the development, manufacturing and commercialization of life-saving vaccines.
Here are some key points about Bavarian Nordic:
- Vaccines: Bavarian Nordic is known for its expertise in the development of vaccines. They have a particular focus on vaccines for infectious diseases, including smallpox, rabies, and Ebola. The company’s smallpox vaccine, known as IMVAMUNE, is designed for individuals with certain health conditions for whom traditional smallpox vaccines may not be suitable.
- Cancer Immunotherapies: In addition to infectious disease vaccines, Bavarian Nordic is involved in the development of cancer immunotherapies. Their cancer vaccine candidate, PROSTVAC, is being investigated in clinical trials for the treatment of prostate cancer.
- Collaborations and Partnerships: Bavarian Nordic has engaged in collaborations and partnerships with various organizations and government agencies. These collaborations aim to advance research, development, and the production of vaccines.
Address:
Philip Heymans Alle 3
Hellerup 16 2900 DENMARK
Product Approval Dates
20‐OCT‐1997 Rabies Vaccine
24‐SEP‐2019 Smallpox and Monkeypox Vaccine, Live, Non‐replicating